Compare LXRX & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXRX | KFRC |
|---|---|---|
| Founded | 1995 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.6M | 882.9M |
| IPO Year | 2000 | 1996 |
| Metric | LXRX | KFRC |
|---|---|---|
| Price | $2.34 | $56.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.15 | ★ $39.67 |
| AVG Volume (30 Days) | ★ 2.7M | 261.9K |
| Earning Date | 05-01-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.42% |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ 1.19 |
| Revenue | $49,803,000.00 | ★ $1,329,007,000.00 |
| Revenue This Year | N/A | $2.78 |
| Revenue Next Year | N/A | $4.32 |
| P/E Ratio | ★ N/A | $128.39 |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.02 | $24.49 |
| 52 Week High | $2.68 | $61.68 |
| Indicator | LXRX | KFRC |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 66.51 |
| Support Level | $2.04 | $26.23 |
| Resistance Level | $2.61 | $60.70 |
| Average True Range (ATR) | 0.15 | 2.42 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 65.12 | 68.85 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Kforce Inc is a solutions firm specializing in technology, finance, accounting, and other professional staffing services. The company operates two business segments: the Technology segment, which provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. The FA segment offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting, business and cost analysis; and taxation and treasury. The majority of revenue is earned through the Technology segment.